Vaccine makers to lobby for higher immunization coverageSeptember 15th, 2010 - 11:19 pm ICT by IANS
Hyderabad, Sep 15 (IANS) Vaccine manufacturers in India Wednesday formed a pressure group to lobby for increasing the immunization coverage in India, which is lower than even in the African countries.
Five leading manufacturers announced the formation of Vaccine Manufacturers’ Association (VAM) which will work as the mouthpiece of the Indian vaccine industry.
A representative told a news conference here that they would urge the government to increase public healthcare aid which is currently one percent of the GDP and to add new vaccines to the list of vaccines under the national immunization programme.
The association, which has brought together Bharat Biotech, Biological E, Panacea Biotech, Serum Institute and Shantha Biotechnics, will urge the government to add new vaccines to the programme.
Krishna Ella, President of VAM and CMD of Bharat Biotech, pointed out that the number of vaccines in India’s national immunization programme remained at five since 1975 while countries like Brazil with less population had 15 vaccines in their national programmes.
The vaccine manufacturers pointed out that while they were exporting vaccines for measles to 140 countries the same were not being utilized in India.
“The immunization coverage in India is 50 to 53 percent, which is much lower than even the African countries who have achieved the UN Millennium Development Goal with a coverage of 80 percent,” said S.S. Jadhav, executive director, Serum Institute of India Limited.
Even a small country like Bangladesh has 95 percent immunization coverage, he said.
The vaccine manufacturers said the low coverage was despite the fact that most of the vaccines produced by them cost less than the price of a cup of tea. They pointed out that their 90 percent business came from exports while only 10 percent vaccines were used in India.
India is presently spending $100 million on vaccine purchase, which is much lower than $175 million spent by a small country like Pakistan.
The manufacturers suggested that India spend 10 percent of the healthcare budget on vaccines to ensure that every child is vaccinated and to save millions of lives from infectious diseases.
The association would urge the government to strengthen vaccine research and delivery mechanism.
Stating that bureaucratic and political interference was hindering the efforts to increase immunization coverage and the growth of vaccine industry, the association demanded autonomy to the Drugs Controller General of India (DCGI), the Central Research Institute (CRI), Kasauli, and the National Institute for Biological Standards and Control (NIBSC).
- Pune firm slashes pentavalent vaccine prices 60 percent - Jun 13, 2011
- Indigenous H1N1 vaccine launched - Jun 03, 2010
- Oral Cholera Vaccine trial successfully completed in Kochi - Dec 18, 2010
- Swine flu vaccine yet to hit Delhi markets - Jun 06, 2010
- Cuba to start clinical trials of pneumonia vaccine - May 04, 2012
- PFCs weaken immune response to vaccine shots in childhood - Jan 25, 2012
- India-made H1N1 vaccine launched (Lead) - Jun 03, 2010
- Poonawalla group acquires Dutch global vaccine company - Jul 05, 2012
- Over 250 companies to participate in BioAsia 2012 - Feb 07, 2012
- India's Bharat Biotech to sell $1 diarrhoea vaccine - Jun 06, 2011
- Swine flu vaccine in 'four to seven months', says government - Aug 07, 2009
- Cuba to test new AIDS vaccine - Mar 07, 2012
- Pune institute in global race for swine flu vaccine - Aug 12, 2009
- India scrambles for germ-free eggs for swine flu vaccines - Aug 09, 2009
- Indian vaccine to save 250 million lives in Africa - Mar 01, 2011
Tags: african countries, cup of tea, immunization coverage, india india, india limited, krishna, manufacturers association, measles, millennium development, mouthpiece, national immunization, national programmes, panacea, pressure group, public healthcare, serum institute of india, shantha biotechnics, vaccine manufacturers, vaccine purchase, vaccines